Leerink Partners analyst David Risinger maintained a Hold rating on HilleVax, Inc (HLVX – Research Report) on November 7 and set a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback